|
|
|
|
Greg W. Smith, Ph.D.
Production & Quality Control Coordinator
|
|
Dr. Greg Smith has held a variety of positions relating to the regulation, manufacture and testing of both biological and pharmaceutical therapeutic goods. He has had more than 10 years experience with the Therapeutic Goods Administration (TGA) and the associated laboratories (TGAL) in Australia. This included roles as the Head of the TGAL Virology Unit and as a Senior GMP auditor (blood & tissue products). He has also worked in human influenza vaccine process development at CSL Ltd and more recently for Pfizer Animal Health in Australia as the leader of the Viral Vaccine Sub-Team of the Bioprocess Improvement Group. Greg has also served as Regulatory Affairs Manager with the Australian Red Cross Blood Service and undertaken a number of short-term consultancies on behalf of WHO and relating to vaccine regulation in China, Viet Nam, the Philippines and Pakistan. Greg joins the IVI Vaccine Process & Technology Section working on the CHOVI program.
e-mail : gwsmith@ivi.int
|
|
|
|
|
|
|
|
|
Nathalie Mielcarek, Ph.D.
Scientist-Molecular Immunology
|
|
Dr. Nathalie Mielcarek received her Ph.D. in 1996 from University of Sciences and Technologies, Lille, France under the mentorship of Prof. A. Capron. The goal of her thesis was to express a Schistosoma mansoni antigen by the respiratory pathogen Bordetella pertussis and to evaluate the protective efficacy of this recombinant bacteria in a mouse model. During her postdoctoral training in Department of Medical Microbiology and Immunology, Goteborg, Sweden, headed by Prof. J. Holmgren, she participated, under the supervision of Dr. C. Czerkinsky, in the development of anti-inflammatory therapeutic vaccines against S. mansoni using Sm28GST and parasite egg antigens chemically conjugated to the B subunit of cholera toxin. She then joined the laboratory of Molecular Mechanisms of Microbial Pathogenesis (Inserm U629), Pasteur Institute of Lille, France headed by Dr. C. Locht, where her main focus was to develop a highly attenuated B. pertussis as an alternative to the currently available vaccines against whooping-cough. She obtained a permanent position as research scientist at INSERM (National Institute for Health and Medical Research) in France. She is now detached at IVI and started to work at the Laboratory Science Division as Scientist-Molecular Immunology focusing on neonatal vaccinology.
e-mail : nmielcarek@ivi.int
|
|
|
|
|
|
|
|
|
Huan Huu Nguyen, Ph.D.
Scientist-Molecular Immunology
|
|
Dr. Huan H. Nguyen graduated (M.S. in Biology) from the Faculty of Natural Sciences, the Charles University in Prague, Czech Republic. In 1992 he received his Ph.D. in immunology from the Institute of Microbiology, the Czech Academy of Sciences, Prague. For his postdoctoral studies he joined the laboratory of Dr. Jiri Mestecky, Department of Microbiology at University of Alabama at Birmingham, USA in 1994 and has been appointed as a Research Assistant Professor of Microbiology since 2000. His research has focused on the effector mechanisms of heterosubtypic immunity (HSI) to influenza A virus infections. His studies published in Virology, Journal of Virology, and Journal of Infectious Diseases suggest novel approaches for the development of preventive and therapeutic vaccines to protect against infections with different subtypes of influenza viruses. He joined as Scientist-Molecular Immunology, Lab. Science Div as of Sep. 18, 2006.
e-mail : hhnguyen@ivi.int
|
|
|
|
|
|
|
|
|
Dong Wook Kim, Ph.D.
Research Scientist
|
|
Dong Wook Kim received Ph.D in 1997 from Korea Advanced Institute of Science and Technology (KAIST). Under mentorship of Professor Joonho Choe, he studied hepatitis C virus RNA helicase. His first post doc training was in Dr. E. Wimmer's lab at State Univ. of New York in Stony Brook. His research subject was translation and replication of RNA virus. He also worked on eucaryotic DNA replication mechanism during his second post doc training in Dr. Y.S. Seo's lab at Samsung biomedical research institute. He was selected as an IVI post doc fellow and studied Shigella flexneri virulence factors in Dr. P. Sansonetti's lab at Pasteur Institute, France. He started working at Microbiology laboratory as a research scientist as of July 01, 2004. His main work at IVI is bacterial strain collection, bacterial genotyping, and bacterial virulence factors.
e-mail : dwkim@ivi.int
|
|
|
|
|
|
|
|
|
Manki Song, Ph.D.
Research Scientist
|
|
Dr. Man Ki Song joined IVI as a research scientist in July 01, 2004. Dr. Song received his B.S. degree from Seoul National University in 1992, and M.S. and Ph.D. degrees from Pohang University of Science and Technology (POSTECH), in Viral Immunology under Prof. Young-Chul Sung. He continued his Postdoctoral work in the Prof Young-Chul Sung's laboratory on the development of HBV and HCV vaccines. He was selected as IVI postdoctoral fellow in 2001 and carried out research at Prof. Myron Levine's Center for Vaccine Development (CVD) at University of Maryland, School of Medicine, Baltimore, MD. During the training period, his research focused on the development of new generation measles vaccines using naked DNA, attenuated Shigella and Salmonella.
e-mail : mksong@ivi.int
|
|
|
|
|
|
|
|
|
Giulietta Saletti
Clinical Laboratory Scientist
|
|
Giulietta Saletti received her master degree from the University of Siena, Italy, and joined the IVI Lab Sciences Division. Giulietta has gained more than 10 years of research experience at Novartis Vaccines (formerly Chiron Vaccines). The work dealt with analyses of immune responses to HCV in pre-clinical models (mouse and chimpanzee) and in phase 1 human clinical trials of hepatitis C virus (HCV) candidate vaccines. Furthermore, she studied the role of the HCV receptor CD81 in human B lymphocyte activation and its relevance to HCV-associated B lymphocyte disorders.
Giulietta also contributed to the development of a candidate vaccine against the SARS virus and to the evaluation of various adjuvants for enhancing immune response to influenza virus vaccines.
e-mail : gsaletti@ivi.int
|
|
|
|
|
|
|
|
|
Mi-Na Kweon, Ph.D.
Chief of Mucosal
immunology section
|
|
Mi-Na
Kwoen, Ph.D., Chief of the Mucosal Immunology
Section, received her bachelor's degree in Nutrition and
Food Science from Pusan Women's University in 1984, her
master's degree in Nutrition and Food Science from National
Fisheries University of Pusan in 1990, and her Ph.D. from
the Department of Nutrition, School of Medicine, University
of Tokushima, Japan, in 1994. Then she completed a three-year
postdoctoral program at the University of Alabama at Birmingham
in the United States. She served as Assistant Professor
in the Department of Mucosal Immunology, at the Research
Institute for Microbial Diseases, Osaka University in
Japan, before joining the IVI.
e-mail : mnkweon@ivi.int
|
|
|
|
|
|
|
|
|
Konrad Stadler, Ph.D.
Senior Scientist-Molecular Virology
|
|
Konrad Stadler, Ph.D., Senior Scientist-Molecular Virology, joined the International Vaccine Institute as Head of the Molecular Biology Department in January 2007. He received his master degree in Biochemistry and the doctoral degree in Virology from the University of Vienna, Austria. Subsequently, he spent three years as a post-doctoral fellow at the Veterinary Faculty, University of Utrecht, the Netherlands. In 2001 he was awarded with a Marie Curie individual fellowship and he moved to Novartis Vaccines, former Chiron Vaccines, Siena, Italy, where he became senior scientist in 2004. His main research interests through his career were vaccine development against flaviviruses, the SARS corona virus, and influenza virus.
e-mail : kstadler@ivi.int
|
|
|
|
|
|
|
|
|
Rodney Carbis, B.Sc.
Senior Scientist
|
|
Rodney
Carbis worked for CSL, an Australian vaccine and
blood products manufacturer, for 16 years. For the last
four years at CSL, he was head of Influenza Vaccine research
and development. This position involved developing and
implementing improvements to the vaccine manufacturing
process, as well as validation of new methodology discussions
and submission of documentation to the National Regulatory
Authority (TGA). Due to the changing nature of the Influenza
virus the responsibilities also required the preparation
of new seed lots and reference reagents for quality control
and lot release testing.
As well as working with Influenza, Rodney spent time
in the virus testing section Quality Control. This involved
testing human and veterinary viral vaccines and serum
products for potency both in vitro and in vivo. After
CSL Rodney worked for Sartorius Australia (a filtration
and fermentor manufacturer) as technical manager where
he worked with vaccine and pharmaceutical companies
in Australia and Asia helping to develop downstream
processes and optimizing sterilizing filtration.
Rodney joined IVI in June 2003 as senior scientist
in charge of process development. Since joining IVI
he has been involved in vaccine technology transfer,
and has worked closely with Cholera and Typhoid vaccine
manufacturers in the Asia Pacific region. He is also
leading a team to develop a Shigella vaccine at IVI.
e-mail : rcarbis@ivi.int
|
|
|
|
|
|
|
|
|
Jongsik Chun, Ph. D.
Senior Adjunct Scientist, Molecular Microbiology Department
|
|
Dr.
Jongsik Chun
e-mail : jchun@ivi.int
|
|
|
|
|
|
|
|
|
Sung Moo Park, M.Sc.
Research Assistant II
|
|
Mr.
SungMoo Park
e-mail : spark@ivi.int
|
|
|
|
|
|
|
|
|
Seung Hyun Han, Ph.D.
Adjunct Chief of Clinical Immunology
|
|
Dr. Seung Hyun Han
e-mail : shhan@ivi.int
|
|
|
|
|
|
|
|
|
Sun Young Chang, Ph.D.
Post-Doctoral Fellow
|
|
Dr. Sun-Young Chang
e-mail : sychang@ivi.int
|
|
|
|
|
|
|
|
|
Jae Seung Yang, M.Sc.
Research Engineer
|
|
Mr. Jae Seung Yang
e-mail : jsyang@ivi.int
|
|
|
|
|
|
|
|
|
Seok Seong Kang
Post-Doctoral Fellow
|
|
Mr. Seok Seong Kang
e-mail : sskang@ivi.int
|
|
|
|
|
|
|
|
|
.jpg)
HyunJeong Ko
Post-Doctoral Fellow
|
|
Mr. HyunJeong Ko
e-mail : hjko@ivi.int
|
|
|
|
|
|
|
|
|
Sang Uk Seo
Post-Doctoral Fellow
|
|
Mr. Sang Uk Seo
e-mail : suseo@ivi.int
|
|
|
|
|
|
|
|
|
Byoung-Shik Shim, M.S.
Research Assistant II
|
|
Mr. Byoung-Shik Shim
e-mail : bsshim@ivi.int
|
|
|
|
|
|
|
|
|
Yoon Seong Jeon, M.S.
Bioinformatician
|
|
Mr. Yoon-Seong Jeon
e-mail : ysjeon@ivi.int
|
|
|
|
|
|
|
|
|
Hyun Suh Kim, M.S.
Research Assistant II
|
|
Ms. Kim, Hyun Suh
e-mail : hskim1@ivi.int
|
|
|
|
|
|
|
|
|
Pilim Choi, B.A.
Senior Administrative Assistant
|
|
Pilim Choi
e-mail : pchoi@ivi.int
|
|
|
|
|
|
|
|
|
Ryang Yeo Kim, M.Sc.
Research Assistant II
|
|
Ryang Yeo Kim
e-mail : rykim@ivi.int
|
|
|
|
|
|
|
|
|
Hae Jung Park, M.S
Research Assistant II
|
|
Hae Jung Park
e-mail : hjpark@ivi.int
|
|
|
|
|
|
|
|
|
Eun Jin Kim, B.S
Research Assistant II
|
|
Eun Jin Kim
e-mail : ejkim@ivi.int
|
|
|
|
|
|
|
|
|
So Jung An, B.S
Research Assistant II
|
|
So Jung An
e-mail : sjan@ivi.int
|
|
|
|
|
|
|
|
|
Neha Kothari
Associate Research Scientist
|
|
Neha Kothari
e-mail : nkothari@ivi.int
|
|
|
|
|
|
|
|
|
Sudeep Kothari
Research Scientist
|
|
Sudeep Kothari
e-mail : skotahri@ivi.int
|
|
|
|
|
|
|
|
|
Jeong Ah Kim, M.S.
Research Assistant II
|
|
Jeong Ah Kim
e-mail : jakim@ivi.int
|
|
|
|
|
|
|
|
|
Hyun Song Lee, B.A.
Administrative Assistant II
|
|
Hyun Song Lee
e-mail : hslee@ivi.int
|
|
|
|
|
|
|
|
|
Hyo Jeong Han, B.A.
Safety & Environment Coordinator
|
|
Hyo Jeong Han
e-mail : hjhan@ivi.int
|
|
|
|
|
|
|
|
|
Doo hee Shim, B.A.
Project Research Assistant II
|
|
Doo hee Shim, B.A.
e-mail : dhshim@ivi.int
|
